Lupin receives US FDA approval for Dapagliflozin tablets EP News Bureau Apr 8, 2026 Approval confirms bioequivalence to Farxiga for approved indications
Inventia enters the U.S. market with FDA approved Dapagliflozin tablets EP News Bureau Apr 8, 2026 Approval grants eligibility for 180-day shared generic drug exclusivity
Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA EP News Bureau Apr 7, 2026 Approval grants eligibility for 180-day shared generic drug exclusivity
